Harris Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.17B | Buy |
12,959,939
+695,236
| +6% | +$63.8M | 1.57% | 20 |
|
|
2025
Q4 | $1.1B | Buy |
12,264,703
+7,514,136
| +158% | +$712M | 1.4% | 28 |
|
|
2025
Q3 | $468M | Buy |
4,750,567
+1,018,466
| +27% | +$101M | 0.75% | 49 |
|
|
2025
Q2 | $340M | Buy |
+3,732,101
| New | +$361M | 0.55% | 55 |
|
|
2022
Q2 | – | Sell |
-39,663
| Closed | -$5.07M | – | 144 |
|
|
2022
Q1 | $5.07M | Sell |
39,663
-262,815
| -87% | -$31.7M | 0.01% | 126 |
|
|
2021
Q4 | $37.3M | Buy |
302,478
+201
| +0.1% | +$26.3K | 0.06% | 101 |
|
|
2021
Q3 | $43M | Sell |
302,277
-1,607
| -0.5% | -$236K | 0.07% | 99 |
|
|
2021
Q2 | $47.4M | Sell |
303,884
-4,460
| -1% | -$722K | 0.08% | 95 |
|
|
2021
Q1 | $47.9M | Sell |
308,344
-99,997
| -24% | -$15.5M | 0.08% | 99 |
|
|
2020
Q4 | $61.1M | Sell |
408,341
-1,185
| -0.3% | -$167K | 0.12% | 95 |
|
|
2020
Q3 | $54.1M | Sell |
409,526
-2,575
| -0.6% | -$336K | 0.13% | 94 |
|
|
2020
Q2 | $47.8M | Buy |
412,101
+115,554
| +39% | +$13.3M | 0.12% | 96 |
|
|
2020
Q1 | $29.1M | Buy |
296,547
+216,460
| +270% | +$28.4M | 0.08% | 95 |
|
|
2019
Q4 | $11.6M | Sell |
80,087
-5,743
| -7% | -$793K | 0.02% | 116 |
|
|
2019
Q3 | $11.4M | Sell |
85,830
-2,840
| -3% | -$367K | 0.02% | 112 |
|
|
2019
Q2 | $10.1M | Sell |
88,670
-1,133
| -1% | -$133K | 0.02% | 111 |
|
|
2019
Q1 | $11.1M | Sell |
89,803
-2,745
| -3% | -$312K | 0.02% | 111 |
|
|
2018
Q4 | $9.32M | Sell |
92,548
-122,266
| -57% | -$13.7M | 0.02% | 110 |
|
|
2018
Q3 | $27.4M | Sell |
214,814
-12,507
| -6% | -$1.49M | 0.04% | 106 |
|
|
2018
Q2 | $24.6M | Buy |
227,321
+52,520
| +30% | +$5.72M | 0.04% | 106 |
|
|
2018
Q1 | $18.5M | Buy |
+174,801
| New | +$20.3M | 0.03% | 107 |
|
Other funds holding ZBH
VCM
VPM
